Processing and presentation of insulin. III. Insulin degrading enzyme: a neutral metalloendoproteinase that is non-homologous to classical endoproteinases mediates the processing of insulin epitopes for helper T cells.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  International Immunology

• Publication date

  1992-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/INTIMM/4.10.1161PMID 1283335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Possible role of cell surface insulin degrading enzyme in cultured human lymphocytes

  2005cited by this paper
• Influence of antigen processing on thymic T-cell selection.

  1991cited by this paper
• Reduction of disulfide bonds during antigen processing: evidence from a thiol-dependent insulin determinant

  1991cited by this paper
• Flexibility of the T cell repertoire. Self tolerance causes a shift of T cell receptor gene usage in response to insulin

  1990cited by this paper
• Selective degradation of insulin within rat liver endosomes

  1990cited by this paper
• Processing without proteolytic cleavage is required for recognition of insulin by T cells

  1990cited by this paper
• Degradation of Insulin and Insulin-Like Growth Factors by Enzyme Purified From Human Erythrocytes: Comparison of Degradation Products Observed With A14- and B26-[125I]monoiodoinsulin

  1989cited by this paper
• Biological properties of an initial degradation product of insulin by insulin-degrading enzyme.

  1989cited by this paper
• Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen-presenting B cells.

  1989cited by this paper
• Identification of insulin intermediates and sites of cleavage of native insulin by insulin protease from human fibroblasts.

  1989cited by this paper
• Identification of proteases that process distinct epitopes on the same protein.

  1989cited by this paper
• Antigen Processing for Presentation to T Lymphocytes: Function, Mechanisms, and Implications for the T‐Cell Repertoire

  1988cited by this paper
• Processing Requirements for the Recognition of Insulin Fragments by Murine T cells

  1988cited by this paper
• Isolation of insulin degradation products from endosomes derived from intact rat liver.

  1988cited by this paper
• Degradation products of insulin generated by hepatocytes and by insulin protease.

  1988cited by this paper
• Facts on the Fragmentation of Antigens in Presenting Cells, on the Association of Antigen Fragments with MHC Molecules in Cell‐Free Systems, and Speculation on the Cell Biology of Antigen Processing

  1988cited by this paper
• Ultrastructural study of internalization and recycling of antigen by antigen presenting cells.

  1988cited by this paper
• Insulin degradation: mechanisms, products, and significance.

  1988cited by this paper
• Pathways of Processing of Insulin by Antigen‐Presenting Cells

  1988cited by this paper
• Antigen processing and the human T cell receptor repertoire for insulin.

  1988cited by this paper
• Influence of antigen processing on immune responsiveness.

  1988cited by this paper
• The Biochemistry and Cell Biology of Antigen Processing

  1988cited by this paper
• Selective inhibition of antigen presentation to cloned T cells by protease inhibitors.

  1988cited by this paper
• T cell autoreactivity to insulin in diabetic and related non-diabetic individuals.

  1988cited by this paper
• Identification of A chain cleavage sites in intact insulin produced by insulin protease and isolated hepatocytes.

  1987cited by this paper
• Processing and presentation of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin A loop-specific T cells.

  1987cited by this paper
• Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease.

  1986cited by this paper
• Binding of immunogenic peptides to Ia histocompatibility molecules

  1985cited by this paper
• Idiotypic analysis of anti-I-Ak monoclonal antibodies. I. Production and characterization of syngeneic anti-idiotypic mAb against an anti-I-Ak mAb.

  1984cited by this paper
• Fine specificity of cloned insulin-specific T cell hybridomas: evidence supporting a role for tertiary conformation.

  1983cited by this paper
• Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing

  1983cited by this paper

• From virus to diabetes therapy: Characterization of a specific insulin‐degrading enzyme inhibitor for diabetes treatment

  2021cites this paper
• Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme

  2021influential citation
• Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer’s disease?

  2016cites this paper
• Hyperglycaemia and hyperinsulinaemia: is insulin-degrading enzyme the missing link?

  2009cites this paper
• Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing.

  2007cites this paper
• Activated T lymphocytes in Type 2 diabetes: implications from in vitro studies.

  2003cites this paper
• Thymic expression of insulin‐related genes in an animal model of autoimmune type 1 diabetes

  2001cites this paper
• Insulin Degradation and Insulin‐Degrading Enzyme

  2001cites this paper
• Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation*

  1998cites this paper
• Insulin degradation: progress and potential.

  1998cites this paper
• Insulin-degrading enzyme does not require peroxisomal localization for insulin degradation.

  1997cites this paper
• Insulin-Degrading Enzyme Does Not Require Peroxisomal Localization for Insulin Degradation.

  1997cites this paper
• Major Histocompatibility Complex Class II Molecules Function as a Template for the Processing of a Partially Processed Insulin Peptide into a T-cell Epitope

  1996cites this paper
• Naturally processed heterodimeric disulfide-linked insulin peptides bind to major histocompatibility class II molecules on thymic epithelial cells.

  1994cites this paper
• Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily.

  1993cites this paper
• Functional analysis of conserved residues in the active site of insulin-degrading enzyme.

  1993cites this paper